Healthcare >> Analyst Interviews >> January 26, 2004


DAVID MARTIN is the senior biotechnology analyst at Dundee Securities in Toronto, Canada. Prior to joining Dundee, he was involved in biotech research and investment banking at another Canadian firm, and has also worked for a Big Four accounting firm and a European pharmaceutical company. He earned an MBA from the Richard Ivey School of Business and a PhD from the University of Western Ontario, based on work conducted at the London Cancer Center, the Ontario Cancer Institute and the University of Kentucky. His research took him to Italy, where he worked on a year-long scholarship at a cancer institute near Milan. Profile
TWST: May we start with a quick overview of your coverage at Dundee

Securities? Are there certain areas of biotech that you focus on?

Mr. Martin: Actually, because the Canadian biotech sector